Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease il13 gene
Symptom C0009763|conjunctivitis
Sentences 10
PubMedID- 23663473 Aims: to identify the incidence of allergic conjunctivitis in patients with allergic rhinitis.
PubMedID- 25685162 Background: the effect of sublingual timothy grass immunotherapy tablet 2800 bau (grass slit-t) has been evaluated in three north american trials in adults and children who have allergic rhinitis with or without conjunctivitis (ar/c).
PubMedID- 25535643 (sublingual tablet 2,800 BAU) The objective is to conduct a systematic review of the beneficial and harmful effects of timothy grass (phleum pratense) standardized allergenic extract (ppae; brand name grastek) 2,800 bau, for the treatment of timothy and related grass pollen-induced allergic rhinitis (ar), with or without conjunctivitis, in adults and children aged five years and older.
PubMedID- 24468255 Background: in north america, few studies have evaluated sublingual immunotherapy for allergic rhinitis with or without conjunctivitis (ar/c); pediatric data are sparse.
PubMedID- 25335122 Background: 300ir 5-grass pollen sublingual immunotherapy tablets have been approved for the treatment of allergic rhinitis (ar) with or without conjunctivitis in adults and children >5 years with grass pollen allergy.
PubMedID- 25636947 Background: the magnitude of effect of sublingual immunotherapy for house dust mite (hdm)-induced allergic rhinitis with or without conjunctivitis is uncertain, partly because there are few well-controlled trials with well-defined doses.
PubMedID- 24019844 Allergic conjunctivitis is closely associated with asthma and allergic rhinitis.
PubMedID- 23706715 Background: ragweed is an important cause of allergic rhinitis with or without conjunctivitis (ar/c) in north america and elsewhere.
PubMedID- 23622121 Background: in north america and europe, millions of patients experience symptoms of allergic rhinitis with or without conjunctivitis (ar/c) on exposure to ragweed pollen.
PubMedID- 21790286 It is indicated for the management of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titer of the specific ige to the grass pollen.

Page: 1